Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mariana Brütt Pacheco, Vânia Camilo, Rui Henrique & Carmen Jerónimo. (2022) Epigenetic Editing in Prostate Cancer: Challenges and Opportunities. Epigenetics 17:5, pages 564-588.
Read now
Read now
Christian Huisman, Monique GP van der Wijst, Fahimeh Falahi, Juul Overkamp, Gellért Karsten, Martijn M Terpstra, Klaas Kok, Ate GJ van der Zee, Ed Schuuring, G Bea A Wisman & Marianne G Rots. (2015) Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics 10:5, pages 384-396.
Read now
Read now
Karla Juárez-Moreno, Rafaela Erices, Adriana S. Beltran, Sabine Stolzenburg, Mauricio Cuello-Fredes, Gareth I. Owen, Haili Qian & Pilar Blancafort. (2013) Breaking through an epigenetic wall. Epigenetics 8:2, pages 164-176.
Read now
Read now
Ashley G. Rivenbark, Sabine Stolzenburg, Adriana S. Beltran, Xinni Yuan, Marianne G. Rots, Brian D. Strahl & Pilar Blancafort. (2012) Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7:4, pages 350-360.
Read now
Read now
Gino Marioni, Stella Blandamura, Marco Lionello, Luciano Giacomelli, Claudia Staffieri, Elena Fasanaro, Enzo Manzato & Alberto Staffieri. (2011) Nuclear MASPIN expression relates to a better prognosis in elderly patients with laryngeal carcinoma. Acta Oto-Laryngologica 131:11, pages 1220-1225.
Read now
Read now
Articles from other publishers (34)
Agustin Sgro, Joseph Cursons, Charlene Waryah, Eleanor A. Woodward, Momeneh Foroutan, Ruqian Lyu, George C. T. Yeoh, Peter J. Leedman & Pilar Blancafort. (2023) Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma. Clinical Epigenetics 15:1.
Crossref
Crossref
Sijie Tang, Zhongli Ling, Jiajia Jiang, Xiang Gu, Yuzhong Leng, Chaohui Wei, Huiying Cheng & Xiaohua Li. (2022) Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects. Frontiers in Oncology 12.
Crossref
Crossref
Behrouz Shademan, Sepideh Masjedi, Vahidreza Karamad, Alireza Isazadeh, Fatma Sogutlu, Mohammad hosein saeedi rad & Alireza Nourazarian. (2022) CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges. Biochemical Genetics 60:5, pages 1446-1470.
Crossref
Crossref
Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri & Pilar Blancafort. (2021) Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy - Methods & Clinical Development 21, pages 592-606.
Crossref
Crossref
Jessica A. Kretzmann, Cameron W. Evans, Colette Moses, Anabel Sorolla, Amy L. Kretzmann, Edina Wang, Diwei Ho, Mark J. Hackett, Benjamin F. Dessauvagie, Nicole M. Smith, Andrew D. Redfern, Charlene Waryah, Marck Norret, K. Swaminathan Iyer & Pilar Blancafort. (2019) Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers. Chemical Science 10:33, pages 7718-7727.
Crossref
Crossref
Colette Moses, Fiona Nugent, Charlene Babra Waryah, Benjamin Garcia-Bloj, Alan R. Harvey & Pilar Blancafort. (2019) Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System. Molecular Therapy - Nucleic Acids 14, pages 287-300.
Crossref
Crossref
Colette Moses, Benjamin Garcia-Bloj, Alan R. Harvey & Pilar Blancafort. (2018) Hallmarks of cancer: The CRISPR generation. European Journal of Cancer 93, pages 10-18.
Crossref
Crossref
Charlene Babra Waryah, Colette Moses, Mahira Arooj & Pilar Blancafort. 2018. Epigenome Editing. Epigenome Editing
19
63
.
Fernando J Bustos, Estibaliz Ampuero, Nur Jury, Rodrigo Aguilar, Fahimeh Falahi, Jorge Toledo, Juan Ahumada, Jaclyn Lata, Paula Cubillos, Berta Henríquez, Miguel V Guerra, Jimmy Stehberg, Rachael L Neve, Nibaldo C Inestrosa, Ursula Wyneken, Marco Fuenzalida, Steffen Härtel, Miguel Sena-Esteves, Lorena Varela-Nallar, Marianne G Rots, Martin Montecino & Brigitte van Zundert. (2017) Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer’s disease mice. Brain 140:12, pages 3252-3268.
Crossref
Crossref
Jessica A. Kretzmann, Diwei Ho, Cameron W. Evans, Janice H. C. Plani-Lam, Benjamin Garcia-Bloj, A. Elaaf Mohamed, Megan L. O'Mara, Ethan Ford, Dennis E. K. Tan, Ryan Lister, Pilar Blancafort, Marck Norret & K. Swaminathan Iyer. (2017) Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA. Chem. Sci. 8:4, pages 2923-2930.
Crossref
Crossref
Benjamin Garcia-Bloj, Colette Moses, Agustin Sgro, Janice Plani-Lam, Mahira Arooj, Ciara Duffy, Shreyas Thiruvengadam, Anabel Sorolla, Rabab Rashwan, Ricardo L. Mancera, Andrea Leisewitz, Theresa Swift-Scanlan, Alejandro H. Corvalan & Pilar Blancafort. (2016) Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system. Oncotarget 7:37, pages 60535-60554.
Crossref
Crossref
Christian Huisman, Monique G P van der Wijst, Matthijs Schokker, Pilar Blancafort, Martijn M Terpstra, Klaas Kok, Ate G J van der Zee, Ed Schuuring, G Bea A Wisman & Marianne G Rots. (2016) Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation. Molecular Therapy 24:3, pages 536-547.
Crossref
Crossref
Priyanga Wijesinghe & Aliccia Bollig-Fischer. 2016. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
1
23
.
JUN ZHOU, QIN HUALONG, PENG ZHOU & FENG GUO. (2015) Different maspin functions in the lung adenocarcinoma A549 and SPC-A1 cell lines. International Journal of Molecular Medicine 36:5, pages 1440-1448.
Crossref
Crossref
Fahimeh Falahi, Agustin Sgro & Pilar Blancafort. (2015) Epigenome Engineering in Cancer: Fairytale or a Realistic Path to the Clinic?. Frontiers in Oncology 5.
Crossref
Crossref
Joshua A. McCarroll, Pei Pei Gan, Rafael B. Erlich, Marjorie Liu, Tanya Dwarte, Sharon S. Sagnella, Mia C. Akerfeldt, Lu Yang, Amelia L. Parker, Melissa H. Chang, Michael S. Shum, Frances L. Byrne & Maria Kavallaris. (2015)
TUBB3
/βIII-Tubulin Acts through the PTEN/AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non–Small Cell Lung Cancer
. Cancer Research 75:2, pages 415-425.
Crossref
Crossref
Rossana Berardi, Francesca Morgese, Agnese Savini, Azzurra Onofri & Stefano Cascinu. 2015. Biomarkers in Cancer. Biomarkers in Cancer
345
358
.
Matthew R. Grimmer, Sabine Stolzenburg, Ethan Ford, Ryan Lister, Pilar Blancafort & Peggy J. Farnham. (2014) Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation. Nucleic Acids Research 42:16, pages 10856-10868.
Crossref
Crossref
Hui Chen, Hinke G Kazemier, Marloes L. de Groote, Marcel H. J. Ruiters, Guo-Liang Xu & Marianne G. Rots. (2014) Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Research 42:3, pages 1563-1574.
Crossref
Crossref
Zhiqiang Liu, Yangyang Shi, Wei Meng, Yufang Liu, Kaixuan Yang, Shuhua Wu & Zhilan Peng. (2013) Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis. Archives of Gynecology and Obstetrics 289:2, pages 373-382.
Crossref
Crossref
Marloes L. de Groote, Hinke G. Kazemier, Christian Huisman, Bernardina T.F. van der Gun, Marijke M. Faas & Marianne G. Rots. (2014) Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells. International Journal of Cancer 134:2, pages 280-290.
Crossref
Crossref
Rossana Berardi, Francesca Morgese, Agnese Savini, Azzurra Onofri & Stefano Cascinu. 2014. Biomarkers in Cancer. Biomarkers in Cancer
1
12
.
Rossana Berardi, Francesca Morgese, Azzurra Onofri, Paola Mazzanti, Mirco Pistelli, Zelmira Ballatore, Agnese Savini, Mariagrazia De Lisa, Miriam Caramanti, Silvia Rinaldi, Silvia Pagliaretta, Matteo Santoni, Chiara Pierantoni & Stefano Cascinu. (2013) Role of maspin in cancer. Clinical and Translational Medicine 2:1.
Crossref
Crossref
Gino Marioni, Elisabetta Zanoletti, Paola Stritoni, Marco Lionello, Luciano Giacomelli, Andrea Gianatti, Laura Cattaneo, Stella Blandamura, Antonio Mazzoni & Alessandro Martini. (2013) Expression of the tumour-suppressor maspin in temporal bone carcinoma. Histopathology 63:2, pages 242-249.
Crossref
Crossref
Christian Huisman, G. Bea A. Wisman, Hinke G. Kazemier, Marcel A.T.M. van Vugt, Ate G.J. van der Zee, Ed Schuuring & Marianne G. Rots. (2013)
Functional validation of putative tumor suppressor gene
C13ORF18
in cervical cancer by Artificial Transcription Factors
. Molecular Oncology 7:3, pages 669-679.
Crossref
Crossref
Pilar Blancafort, Jian Jin & Stephen Frye. (2013) Writing and Rewriting the Epigenetic Code of Cancer Cells: From Engineered Proteins to Small Molecules. Molecular Pharmacology 83:3, pages 563-576.
Crossref
Crossref
Thomas M. Bodenstine, Richard E. B. Seftor, Zhila Khalkhali-Ellis, Elisabeth A. Seftor, Philip A. Pemberton & Mary J. C. Hendrix. (2012) Maspin: molecular mechanisms and therapeutic implications. Cancer and Metastasis Reviews 31:3-4, pages 529-551.
Crossref
Crossref
M. L. de Groote, P. J. Verschure & M. G. Rots. (2012) Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Research 40:21, pages 10596-10613.
Crossref
Crossref
Baozhen ZhangShengyan XiangQiming ZhongYanru YinLiankun GuDajun Deng. (2012)
The
p16-
Specific Reactivation and Inhibition of Cell Migration Through Demethylation of CpG Islands by Engineered Transcription Factors
. Human Gene Therapy 23:10, pages 1071-1081.
Crossref
Crossref
Sabine Stolzenburg, Marianne G. Rots, Adriana S. Beltran, Ashley G. Rivenbark, Xinni Yuan, Haili Qian, Brian D. Strahl & Pilar Blancafort. (2012) Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Research 40:14, pages 6725-6740.
Crossref
Crossref
Haydee Lara, Yuhua Wang, Adriana S. Beltran, Karla Juárez-Moreno, Xinni Yuan, Sumie Kato, Andrea V. Leisewitz, Mauricio Cuello Fredes, Alexei F. Licea, Denise C. Connolly, Leaf Huang & Pilar Blancafort. (2012) Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors. Journal of Biological Chemistry 287:35, pages 29873-29886.
Crossref
Crossref
Brigitte GouletGabriel ChanAnn F. ChambersJohn D. Lewis. (2012)
An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis
1
This article is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process.
. Biochemistry and Cell Biology 90:1, pages 22-38.
Crossref
Crossref
Adriana S. Beltran, Angela Russo, Haydee Lara, Cheng Fan, Paul M. Lizardi & Pilar Blancafort. (2011) Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor. PLoS ONE 6:9, pages e24595.
Crossref
Crossref
Brigitte Goulet, Wendy Kennette, Amber Ablack, Carl O Postenka, M Nicole Hague, Joe S Mymryk, Alan B Tuck, Vincent Giguère, Ann F Chambers & John D Lewis. (2011) Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis. Laboratory Investigation 91:8, pages 1181-1187.
Crossref
Crossref